Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of an oral complementary medicine combination for symptomatic knee osteoarthritis: A double-blind, randomized, placebo-controlled trial.

Osteoarthritis and cartilage·2026

Same author

Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0.

Journal of extracellular vesicles·2026

Same author

SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain.

BMJ open·2026

Same author

Deprescribing in Older People: A Clinical Practice Guideline Summary.

The Medical journal of Australia·2026

Same author

Efficacy and Harms of Opioid Analgesics for Acute Pain: Overview of Systematic Reviews and Meta-analyses.

Drugs·2026

Same author

Urinary Δ<sup>9</sup>-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review.

Pharmacological research·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Extrapulmonary tuberculosis--three cases in the spine.

Andrew J McLachlan¹, Revathy Arulventhan

¹Burwood Nuclear Medicine, Sydney, New South Wales. amc@nucmedburwood.com.au

Australian Family Physician

|April 4, 2013

Summary

This summary is machine-generated.

Extrapulmonary tuberculosis (EPTB) of the spine is rare in Australian primary care. Migrant populations presenting with prolonged back pain warrant consideration for EPTB diagnosis and treatment.

Related Experiment Videos

Last Updated: May 12, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Area of Science:

Infectious Diseases
Spinal Medicine
Public Health

Background:

Tuberculosis (TB) remains a leading global cause of infectious disease mortality.
Extrapulmonary tuberculosis (EPTB) presentations are infrequent in Australian primary care settings.
Spinal EPTB poses diagnostic challenges in non-endemic regions.

Observation:

Three cases of spinal EPTB in migrants from India presenting with chronic back pain (cervical, thoracic, lumbar) are described.
Patients had resided in Australia for 3-8 years, were HIV-negative, and presented with symptoms lasting several months.
Two cases involved potentially unstable spinal conditions, indicating a risk of neurological damage.

Findings:

All patients responded positively to standard anti-tuberculosis multidrug therapy.
Early consideration of EPTB is crucial for timely diagnosis and management.
Prompt treatment can prevent severe neurological complications.

Implications:

Highlights the importance of considering EPTB in the differential diagnosis of persistent back pain, particularly in migrant populations.
Emphasizes the need for increased awareness and diagnostic vigilance among Australian general practitioners regarding spinal EPTB.
Suggests that targeted screening or heightened clinical suspicion may be beneficial for at-risk demographics presenting with back pain.